GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - Medicare and Medicaid payment, Medicare Part D coverage gap, 340B drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
HR 1260, S 515 Patent Reform Act of 2009 - patent law reform S 369 Preserve Access to Affordable Generics Act - patent settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
Torts TOR
HR 5503 Securing Protections for the Injured from Limitations on Liability Act - broader civil justice reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Government Issues GOV
HR 5175, S 3295 Democracy is Strengthened by Casting Light on Spending in Elections Act - campaign finance, treatment of US subsidiaries
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Taxation/Internal Revenue Code TAX
HR 4853 Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 - R&D tax credit HR 422 Heart Disease Education, Analysis Research, and Treatment for Women Act - R&D tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - implementation, Independent Payment Advisory Board, comparative effectiveness research, health information technology, disease prevention/wellness and innovation provisions, biosimilars HR 759 Food and Drug Globalization Act of 2009 - drug safety HR 2892 Department of Homeland Security Appropriations Act, 2010 - drug importation and safety issues HR 5516 Access to Appropriate Immunizations for Veterans Act of 2010 - vaccine access HR 5923, S 3673 Patients' Freedom to Choose Act - use of FSA and HSA dollars for reimbursement of over-the-counter drugs HR 3202 Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S 3397 Secure and Responsible Drug Disposal Act - drug safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
HR 4899 Supplemental Appropriations Act, 2010 - bio-defense funding and the Ryan White CARE Act S 3686 FY 2011 Labor, HHS, Education and Related Agencies Appropriations - immunization funding and the Ryan White CARE Act HR 3082, SA 4887 (enacted PL 111-322) Continuing Appropriations Act, 2011 - provisions pertaining to Ryan White CARE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOHN HERZOG | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.